[
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. DOI: 10.1002/ijc.2921010.1002/ijc.2921025220842
]Search in Google Scholar
[
2. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012: 27:409-19. DOI: 10.1111/j.2041-1014.2012.00663.x10.1111/j.2041-1014.2012.00663.x365331723134607
]Search in Google Scholar
[
3. Atanasova KR, Yilmaz O. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbiol. 2014: 29:55-66. DOI: 10.1111/omi.1204710.1111/omi.12047394914524506890
]Search in Google Scholar
[
4. Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014: 10:e1003933. DOI: 10.1371/journal.ppat.100393310.1371/journal.ppat.1003933396811824676390
]Search in Google Scholar
[
5. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009: 31:1228-39. DOI: 10.1002/hed.2114010.1002/hed.2114019475550
]Search in Google Scholar
[
6. Ahn J, Segers S, Hayes RB. Periodontal Disease, Porphyromonas Gingivalis (P. gingivalis) Serum Antibody Levels and Orodigestive Cancer Mortality. Carcinogen-esis. 2012: 33:1055-8. DOI: 10.1093/carcin/bgs11210.1093/carcin/bgs112333451422367402
]Search in Google Scholar
[
7. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009: 18:2406-12. DOI: 10.1158/1055-9965.EPI-09-033410.1158/1055-9965.EPI-09-033419745222
]Search in Google Scholar
[
8. Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Cont. 2012: 23:399-404. DOI: 10.1007/s10552-011-9892-710.1007/s10552-011-9892-7376714022271008
]Search in Google Scholar
[
9. Han YW, Houcken W, Loos BG, Schenkein HA, Tezal M. Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer. Adv Dent Res. 2014: 26:47-55. DOI: 10.1177/002203451452833410.1177/002203451452833424736704
]Search in Google Scholar
[
10. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 1995: 55:949-56.
]Search in Google Scholar
[
11. Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F. TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis. Laryngoscope. 2008: 118:1395-9. DOI: 10.1097/MLG.0b013e318174e09b10.1097/MLG.0b013e318174e09b18496150
]Search in Google Scholar
[
12. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG et al. Evidence that TNFTNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene. 2007: 26:1385-97. DOI: 10.1038/ sj.onc.120994510.1038/sj.onc.120994516953224
]Search in Google Scholar
[
13. Sherr CJ. Cancer cell cycles. Science. 1996:274(5293):1672-7. DOI: 10.1126/science.274.5293.167210.1126/science.274.5293.16728939849
]Search in Google Scholar
[
14. Witzel II, Koh LF and Perkins ND: Regulation of cyclin D1 gene expression. Biochem Soc Trans 2010: 38:217-22. DOI: 10.1042/BST038021710.1042/BST038021720074063
]Search in Google Scholar
[
15. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 1995:11(5):1005-11.
]Search in Google Scholar
[
16. Soloman DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, et al. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem. 2003 :278(16): 30339-47.10.1074/jbc.M30396920012746453
]Search in Google Scholar
[
17. Atac A, Riecke B, Assaf AT, Gröbe A, Friedrich RE, Heiland M et. al. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma. Anticancer Res. 2014:34(1):235-8.
]Search in Google Scholar
[
18. Murali A, Nalinakumari KR, Thomas S, Kannan S. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014:52(7):652-8. DOI: 10.1016/j.bjoms.2014.05.01010.1016/j.bjoms.2014.05.01024947332
]Search in Google Scholar
[
19. Liu W, Zhu E, Wang R, Wang L, Gao L, Yang X, Liu T. Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population. Cancer Epidemiol. 2011:35(4):e12-7. DOI: 10.1016/j.canep.2010.11.00110.1016/j.canep.2010.11.00121185249
]Search in Google Scholar
[
20. Tsai MH, Tsai CW, Tsou YA, Hua CH, Hsu CF, Bau DT. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan. Anticancer Res. 2011:31(1):227-31.
]Search in Google Scholar
[
21. Gomes CC, Drummond SN, Guimarães AL, Andrade CI, Mesquita RA, Gomez RS. P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med. 2008:37(3):151-6. DOI: 10.1111/j.1600-0714.2007.00604.x10.1111/j.1600-0714.2007.00604.x18251939
]Search in Google Scholar
[
22. Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol. 2006:42(6):607-13. DOI: 10.1016/j.oraloncology.2005.10.01910.1016/j.oraloncology.2005.10.01916488657
]Search in Google Scholar
[
23. Holley SL, Matthias C, Jahnke V, Fryer AA, Strange RC, Hoban PR. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol. 2005:41(2):156-60. DOI: 10.1016/j.oraloncology.2004.08.00510.1016/j.oraloncology.2004.08.00515695117
]Search in Google Scholar
[
24. Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, Simpson AJ, Caballero OL et al. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol. 2004:40(6):604-10. DOI: 10.1016/j. oraloncology.2003.12.009
]Search in Google Scholar
[
25. Wong YK, Lin SC, Chang CS, Tseng YH, Liu CJ, Lin HC et al. Cyclin D1 genotype in areca-associated oral squamous cell carcinoma. J Oral Pathol Med. 2003:32(5):265-70. DOI: 10.1034/j.1600-0714.2003.00131.x10.1034/j.1600-0714.2003.00131.x12694349
]Search in Google Scholar
[
26. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001:22(8):1195-9. DOI: 10.1093/carcin/22.8.119510.1093/carcin/22.8.1195
]Search in Google Scholar
[
27. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J et al. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 1998:4(10):2411-8.
]Search in Google Scholar
[
28. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004:20(9):439-44. DOI: 10.1016/j.tig.2004.06.01410.1016/j.tig.2004.06.014
]Search in Google Scholar
[
29. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010: 25: 603-5. DOI: 10.1007/s10654-010-9491-z10.1007/s10654-010-9491-z
]Search in Google Scholar
[
30. Wu R, Li B. A multiplicative-epistatic model for analyzing interspecific differences in outcrossing species. Biometrics. 1999:2:355-65. DOI: 10.1111/j.0006-341X.1999.00355.x10.1111/j.0006-341X.1999.00355.x
]Search in Google Scholar
[
31. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986:7:177-88. DOI: 10.1016/0197-2456(86)90046-210.1016/0197-2456(86)90046-2
]Search in Google Scholar
[
32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959:4:719-48.
]Search in Google Scholar
[
33. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997: 315:629-34. DOI: 10.1136/ bmj.315.7109.62910.1136/bmj.315.7109.62921274539310563
]Search in Google Scholar
[
34. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C. Trial sequential analysis may establish when firm evidence is reached in cumulative metaanalysis. J. Clin. Epidemiol. 2008:61: 64-75. DOI: 10.1016/j.jclinepi.2007.03.01310.1016/j.jclinepi.2007.03.01318083463
]Search in Google Scholar
[
35. d Brok, J., Thorlund, K., Wetterslev, J., and Gluud, C. Apparently conclusive meta-analyses may be inconclusive-Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int. J. Epidemiol 2009: 38: 287-98. DOI: 10.1093/ije/dyn18810.1093/ije/dyn18818824466
]Search in Google Scholar
[
36. Turner, R. M., Bird, S. M., and Higgins, J. P. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS ONE 2013: 8: e59202. DOI: 10.1371/journal.pone.005920210.1371/journal.pone.0059202360974523544056
]Search in Google Scholar
[
37. Wilson S, Jones L, Couseens C, Kathi H. The links between environmental factors, genetics, and the development of Cancer. Cancer and the Environment: Gene-Enviroment Interaction. National Academies Press (US), 2002.
]Search in Google Scholar
[
38. Morgan, David O. Principles of CDK regulation. Nature 374, no. 6518 (1995): 131-4. DOI: 10.1038/374131a010.1038/374131a07877684
]Search in Google Scholar
[
39. Dowdy, Steven F., Philip W. Hinds, Kenway Louie, Steven I. Reed et al. Weinberg. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993:73(3): 499-511. DOI: 10.1016/0092-8674(93)90137-F10.1016/0092-8674(93)90137-F
]Search in Google Scholar
[
40. Donnellan, R., and R. Chetty. Cyclin D1 and human neoplasia. Molecular Pathology 1998):51:1. DOI: 10.1136/mp.51.1.110.1136/mp.51.1.1
]Search in Google Scholar
[
41. Schoelch ML, Regezi. Cell cycle proteins the development of oral squamous cell carcinoma. Oral Oncol 1999: 35:333-42. DOI: 10.1016/S1368-8375(98)00098-010.1016/S1368-8375(98)00098-0
]Search in Google Scholar
[
42. Todd R, Hind PW, Munger K, Rustgi AK, Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 2002:13:51-61. DOI: 10.1177/15441113020130010610.1177/154411130201300106
]Search in Google Scholar
[
43. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, et al. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene. 1998:16(13):1701-12. DOI: 10.1038/ sj.onc.120169110.1038/sj.onc.1201691
]Search in Google Scholar
[
44. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res.1996:68:67-108. DOI: 10.1016/S0065-230X(08)60352-810.1016/S0065-230X(08)60352-8
]Search in Google Scholar
[
45. Wang L, Wang Z, Gao X, Li X, Sun X, Liu C. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis. Tumour Biol. 2014:35(2):1149-55. DOI: 10.1007/s13277-013-1154-810.1007/s13277-013-1154-824186074
]Search in Google Scholar
[
46. Wang W, Zhao Y, Yang J, Lin B, Gu H, Cao X et al. Cyclin D1 polymorphism and oral cancer: a meta-analysis. Mol Biol Rep. 2013:40(1):87-95. DOI: 10.1007/ s11033-012-2025-x10.1007/s11033-012-2025-x23111452
]Search in Google Scholar